Senior insider sale
CEO at XENON PHARMACEUTICALS INC. — senior position signals high conviction
$4.20M
110K shares
What this filing means
PIMSTONE SIMON N. plans to sell 110K shares of XENON PHARMACEUTICALS INC. valued at approximately $4.20M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/5/2024ACC: 0000950170-24-069439
DirectorOfficer· CEO
Since Sep 2019
110K
Shares to sell
$4.20M
Approx. market value
466.68K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months6
Equity Incentive Grant
See remarks
9/16/2019
95KEquity Incentive Grant
See remarks
3/12/2018
140KEquity Incentive Grant
See remarks
10/23/2017
11KEquity Incentive Grant
See remarks
3/13/2017
140KEquity Incentive Grant
See remarks
3/11/2016
50KEquity Incentive Grant
See remarks
12/18/2015
30.68KTotal acquired466.68K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/16/2019 | Equity Incentive Grant See remarks | 95K | — |
3/12/2018 | Equity Incentive Grant See remarks | 140K | — |
10/23/2017 | Equity Incentive Grant See remarks | 11K | — |
3/13/2017 | Equity Incentive Grant See remarks | 140K | — |
3/11/2016 | Equity Incentive Grant See remarks | 50K | — |
12/18/2015 | Equity Incentive Grant See remarks | 30.68K | — |
| Total | 466.68K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
110K
Market value
$4.20M
6/5/2024
Total
Units
110K
Value
$4.20M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/5/2024 | 110K | $4.20M | NASDAQ | Planned |
| Total | 110K | $4.20M | ||